RETEVMO Overview

Now Approved Journal ad

This ad helped launch Retevmo in HCP publications across the country.

HCP Testing Leave Behind

This leave behind allowed Lilly reps to provide HCPs with detailed information about Retevmo after an initial meeting.

Test for RET diagnostic email

This email showed diagnosticians the importance of testing for RET in order to qualify patients for treatment with Retevmo.